Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) closed at $130.25 on November 5, 2026, down 4.6% from the previous close, on volume of 33,225 shares (30-day average 44,466).
Data as of November 5, 2026.
No headlines found.
No press releases found.
No news found.
Invests in stocks in the S&P MidCap 400 Growth Index composed of the growth companies in the S&P 400. Focuses on closely tracking the index s return which is considered a gauge of overall U.S. mid-cap growth stock returns. Offers high potential for investment growth; share value rises and falls more sharply than that of funds holding bonds. More appropriate for long-term goals where your money s growth is essential.
Vanguard S&P Mid-Cap 400 Growth ETF trades on the ARCA stock market under the symbol IVOG.
As of November 6, 2026, IVOG stock price climbed to $132.24 with 23,531 million shares trading.
IVOG has a beta of 0.92, meaning it tends to be less sensitive to market movements. IVOG has a correlation of 0.53 to the broad based SPY ETF.
IVOG has a market cap of $1.63 billion. This is considered a Small Cap stock.
In the last 3 years, IVOG traded as high as $148.72 and as low as $87.33.
IVOG has outperformed the market in the last year with a price return of +11.3% while the SPY ETF gained +9.7%. However, in the short term, IVOG had mixed performance relative to the market. It has underperformed in the last 3 months, returning -7.9% vs -4.2% return in SPY. But in the last 2 weeks, IVOG shares have fared better than the market returning -1.6% compared to SPY -3.7%.
IVOG support price is $128.55 and resistance is $131.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IVOG shares will trade within this expected range on the day.
